Skip to menu Skip to content Skip to footer

2025

Journal Article

Capturing breast cancer subtypes in cancer registries: insights into real-world incidence and survival

Vaz-Gonçalves, Larissa, Marquart-Wilson, Louise, Protani, Melinda M, Stephensen, Meghan T, Moore, Julie, Morris, Michelle F, Saunus, Jodi M and Reeves, Marina M (2025). Capturing breast cancer subtypes in cancer registries: insights into real-world incidence and survival. Journal of Cancer Policy, 44 100567, 100567-44. doi: 10.1016/j.jcpo.2025.100567

Capturing breast cancer subtypes in cancer registries: insights into real-world incidence and survival

2025

Journal Article

Mean relative error and standard relative deviation

Chatfield, Mark D., Marquart‐Wilson, Louise, Dobson, Annette J. and Farewell, Daniel M. (2025). Mean relative error and standard relative deviation. Statistica Neerlandica, 79 (1) e70001, 1-7. doi: 10.1111/stan.70001

Mean relative error and standard relative deviation

2024

Journal Article

Characterizing the pharmacological interaction of the antimalarial combination artefenomel-piperaquine in healthy volunteers with induced blood-stage Plasmodium falciparum to predict efficacy in patients with malaria

Abd-Rahman, Azrin N., Kaschek, Daniel, Kummel, Anne, Webster, Rebecca, Potter, Adam J., Odedra, Anand, Woolley, Stephen D., Llewellyn, Stacey, Webb, Lachlan, Marquart, Louise, Chalon, Stephan, El Gaaloul, Myriam, Mccarthy, James S., Mohrle, Jorg J. and Barber, Bridget E. (2024). Characterizing the pharmacological interaction of the antimalarial combination artefenomel-piperaquine in healthy volunteers with induced blood-stage Plasmodium falciparum to predict efficacy in patients with malaria. BMC Medicine, 22 (1) 563. doi: 10.1186/s12916-024-03787-0

Characterizing the pharmacological interaction of the antimalarial combination artefenomel-piperaquine in healthy volunteers with induced blood-stage Plasmodium falciparum to predict efficacy in patients with malaria

2024

Journal Article

Corrigendum to “A Randomized Trial of Baby Triple P for Preterm Infants: Child Outcomes at 2 Years of Corrected Age”. J Pediatr. 2019;210:48-54

Colditz, Paul B., Boyd, Roslyn N., Winter, Leanne, Pritchard, Margo, Gray, Peter H., Whittingham, Koa, O’Callaghan, Michael, Jardine, Luke, O’Rourke, Peter, Marquart, Louise, Forrest, Kylee, Spry, Carmen and Sanders, Matthew R. (2024). Corrigendum to “A Randomized Trial of Baby Triple P for Preterm Infants: Child Outcomes at 2 Years of Corrected Age”. J Pediatr. 2019;210:48-54. The Journal of Pediatrics, 275 114293, 114293. doi: 10.1016/j.jpeds.2024.114293

Corrigendum to “A Randomized Trial of Baby Triple P for Preterm Infants: Child Outcomes at 2 Years of Corrected Age”. J Pediatr. 2019;210:48-54

2024

Journal Article

Eating frequency, timing of meals, and sleep duration before and after a randomized controlled weight loss trial for breast cancer survivors

D'cunha, Kelly, Park, Yikyung, Leech, Rebecca M., Protani, Melinda M., Marquart-Wilson, Louise and Reeves, Marina M. (2024). Eating frequency, timing of meals, and sleep duration before and after a randomized controlled weight loss trial for breast cancer survivors. Journal of Cancer Survivorship. doi: 10.1007/s11764-024-01680-6

Eating frequency, timing of meals, and sleep duration before and after a randomized controlled weight loss trial for breast cancer survivors

2024

Journal Article

Use of an emulated trial to investigate the association between use of nitrogen-based bisphosphonates and risk of epithelial ovarian cancer

Tuesley, Karen M., Spilsbury, Katrina, Webb, Penelope M., Pearson, Sallie-Anne, Donovan, Peter, Coory, Michael D., Steer, Christopher B., Stewart, Louise M., Pandeya, Nirmala, Protani, Melinda M., Dixon-Suen, Suzanne, Marquart-Wilson, Louise and Jordan, Susan J. (2024). Use of an emulated trial to investigate the association between use of nitrogen-based bisphosphonates and risk of epithelial ovarian cancer. International Journal of Epidemiology, 53 (4) dyae108, 1-10. doi: 10.1093/ije/dyae108

Use of an emulated trial to investigate the association between use of nitrogen-based bisphosphonates and risk of epithelial ovarian cancer

2024

Journal Article

Longitudinal changes in iron homeostasis in human experimental and clinical malaria

Woolley, Stephen D., Grigg, Matthew J., Marquart, Louise, Gower, Jeremy S.E., Piera, Kim, Nair, Arya Sheela, Amante, Fiona M., Rajahram, Giri S., William, Timothy, Frazer, David M., Chalon, Stephan, McCarthy, James S., Anstey, Nicholas M. and Barber, Bridget E. (2024). Longitudinal changes in iron homeostasis in human experimental and clinical malaria. eBioMedicine, 105 105189, 1-12. doi: 10.1016/j.ebiom.2024.105189

Longitudinal changes in iron homeostasis in human experimental and clinical malaria

2023

Journal Article

Evaluation of a multiphasic parasite clearance profile after treatment of experimental human infection with the investigational anti-malarial M5717 using segmented mixed effect models

Yin, Xiaoyan, Li, Ying, Bagchus, Wilhelmina, Yalkinoglu, Özkan, Bezuidenhout, Deon, Tappert, Aliona, McCarthy, James, Marquart, Louise and Oeuvray, Claude (2023). Evaluation of a multiphasic parasite clearance profile after treatment of experimental human infection with the investigational anti-malarial M5717 using segmented mixed effect models. Malaria Journal, 22 (1) 199, 199. doi: 10.1186/s12936-023-04627-x

Evaluation of a multiphasic parasite clearance profile after treatment of experimental human infection with the investigational anti-malarial M5717 using segmented mixed effect models

2023

Journal Article

Peripheral intravenous catheter material and design to reduce device failure: a systematic review and meta-analysis

Matthews, Robyn, Gavin, Nicole C., Marsh, Nicole, Marquart-Wilson, Louise and Keogh, Samantha (2023). Peripheral intravenous catheter material and design to reduce device failure: a systematic review and meta-analysis. Infection, Disease and Health, 28 (4), 298-307. doi: 10.1016/j.idh.2023.05.005

Peripheral intravenous catheter material and design to reduce device failure: a systematic review and meta-analysis

2023

Journal Article

Perforated intravenous catheter design is acceptable for the administration of contrast-enhanced computed tomography administration in cancer patients: results of a pilot randomised controlled trial

Gavin, Nicole C., Wignall, Elizabeth, Marsh, Nicole, Marquart, Louise, Dobeli, Karen L., O'Brien, Catherine, Verderosa, Anthony D., Totsika, Makrina and Keogh, Samantha (2023). Perforated intravenous catheter design is acceptable for the administration of contrast-enhanced computed tomography administration in cancer patients: results of a pilot randomised controlled trial. The Journal of Vascular Access, 25 (5) 11297298231171422, 1519-1527. doi: 10.1177/11297298231171422

Perforated intravenous catheter design is acceptable for the administration of contrast-enhanced computed tomography administration in cancer patients: results of a pilot randomised controlled trial

2023

Journal Article

blandaltman: a command to create variants of Bland–Altman plots

Chatfield, Mark D., Cole, Tim J., de Vet, Henrica C. W., Marquart-Wilson, Louise and Farewell, Daniel M. (2023). blandaltman: a command to create variants of Bland–Altman plots. The Stata Journal, 23 (3), 851-874. doi: 10.1177/1536867x231196488

blandaltman: a command to create variants of Bland–Altman plots

2023

Journal Article

Characterizing the blood-stage antimalarial activity of tafenoquine in healthy volunteers experimentally infected with plasmodium falciparum

Barber, Bridget E, Abd-Rahman, Azrin N, Webster, Rebecca, Potter, Adam J, Llewellyn, Stacey, Marquart, Louise, Sahai, Nischal, Leelasena, Indika, Birrell, Geoffrey W, Edstein, Michael D, Shanks, G. Dennis, Wesche, David, Moehrle, Joerg J. and McCarthy, James S. (2023). Characterizing the blood-stage antimalarial activity of tafenoquine in healthy volunteers experimentally infected with plasmodium falciparum. Clinical Infectious Diseases, 76 (11), 1919-1927. doi: 10.1093/cid/ciad075

Characterizing the blood-stage antimalarial activity of tafenoquine in healthy volunteers experimentally infected with plasmodium falciparum

2023

Journal Article

Transmission blocking activity of low dose tafenoquine in healthy volunteers experimentally infected with Plasmodium falciparum

Webster, Rebecca, Mitchell, Hayley, Peters, Jenny M., Heunis, Juanita, O'Neill, Brighid, Gower, Jeremy, Lynch, Sean, Jennings, Helen, Amante, Fiona H., Llewellyn, Stacey, Marquart, Louise, Potter, Adam J., Birrell, Geoffrey W., Edstein, Michael D., Dennis Shanks, G., McCarthy, James S. and Barber, Bridget E. (2023). Transmission blocking activity of low dose tafenoquine in healthy volunteers experimentally infected with Plasmodium falciparum. Clinical Infectious Diseases, 76 (3), 506-512. doi: 10.1093/cid/ciac503

Transmission blocking activity of low dose tafenoquine in healthy volunteers experimentally infected with Plasmodium falciparum

2022

Journal Article

Higher mycophenolate dosage is associated with an increased risk of squamous cell carcinoma in kidney transplant recipients

Shao, E. X., Betz-Stablein, B., Marquat, L., Campbell, S., Isbel, N., Green, A. C. and Plasmeijer, E. I. (2022). Higher mycophenolate dosage is associated with an increased risk of squamous cell carcinoma in kidney transplant recipients. Transplant Immunology, 75 101698, 101698. doi: 10.1016/j.trim.2022.101698

Higher mycophenolate dosage is associated with an increased risk of squamous cell carcinoma in kidney transplant recipients

2022

Journal Article

Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

Hakkaart, Christopher, Pearson, John F, Marquart, Louise, Dennis, Joe, Wiggins, George A R, Barnes, Daniel R, Robinson, Bridget A, Mace, Peter D, Aittomäki, Kristiina, Andrulis, Irene L, Arun, Banu K, Azzollini, Jacopo, Balmaña, Judith, Barkardottir, Rosa B, Belhadj, Sami, Berger, Lieke, Blok, Marinus J, Boonen, Susanne E, Borde, Julika, Bradbury, Angela R, Brunet, Joan, Buys, Saundra S, Caligo, Maria A, Campbell, Ian, Chung, Wendy K, Claes, Kathleen B M, GEMO Study Collaborators, EMBRACE Collaborators, Collonge-Rame, Marie-Agnès ... Walker, Logan C (2022). Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers. Communications Biology, 5 (1) 1061, 1061. doi: 10.1038/s42003-022-03978-6

Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

2022

Journal Article

The in-vivo dynamics of Plasmodium falciparum HRP2: implications for the use of rapid diagnostic tests in malaria elimination

Marquart, Louise, Webb, Lachlan, O’Rourke, Peter, Gatton, Michelle L., Hsiang, Michelle S., Kalnoky, Michael, Jang, Ihn Kyung, Ntuku, Henry, Mumbengegwi, Davis R., Domingo, Gonzalo J., McCarthy, James S. and Britton, Sumudu (2022). The in-vivo dynamics of Plasmodium falciparum HRP2: implications for the use of rapid diagnostic tests in malaria elimination. Malaria Journal, 21 (1) 233, 1-14. doi: 10.1186/s12936-022-04245-z

The in-vivo dynamics of Plasmodium falciparum HRP2: implications for the use of rapid diagnostic tests in malaria elimination

2022

Journal Article

Safety, tolerability, pharmacokinetics, and pharmacodynamics of coadministered Ruxolitinib and Artemether-Lumefantrine in healthy adults

Chughlay, M. Farouk, Barnes, Karen I., El Gaaloul, Myriam, Abla, Nada, Möhrle, Jörg J., Griffin, Paul, van Giersbergen, Paul, Reuter, Stephanie E., Schultz, Hayley B., Kress, Anita, Tapley, Peter, Webster, Rebecca A., Wells, Timothy, McCarthy, James S., Barber, Bridget E., Marquart, Louise, Boyle, Michelle J., Engwerda, Christian R. and Chalon, Stephan (2022). Safety, tolerability, pharmacokinetics, and pharmacodynamics of coadministered Ruxolitinib and Artemether-Lumefantrine in healthy adults. Antimicrobial Agents and Chemotherapy, 66 (1) e01584-21, e0158421. doi: 10.1128/AAC.01584-21

Safety, tolerability, pharmacokinetics, and pharmacodynamics of coadministered Ruxolitinib and Artemether-Lumefantrine in healthy adults

2021

Journal Article

Analytical validation of a real-time hydrolysis probe PCR assay for quantifying Plasmodium falciparum parasites in experimentally infected human adults

Wang, Claire Y. T., Ballard, Emma L., Pava, Zuleima, Marquart, Louise, Gaydon, Jane, Murphy, Sean C., Whiley, David, O’Rourke, Peter and McCarthy, James S. (2021). Analytical validation of a real-time hydrolysis probe PCR assay for quantifying Plasmodium falciparum parasites in experimentally infected human adults. Malaria Journal, 20 (1) 181, 181. doi: 10.1186/s12936-021-03717-y

Analytical validation of a real-time hydrolysis probe PCR assay for quantifying Plasmodium falciparum parasites in experimentally infected human adults

2021

Journal Article

Haematological response in experimental human Plasmodium falciparum and Plasmodium vivax malaria

Woolley, Stephen D., Marquart, Louise, Woodford, John, Chalon, Stephan, Moehrle, Joerg J., McCarthy, James S. and Barber, Bridget E. (2021). Haematological response in experimental human Plasmodium falciparum and Plasmodium vivax malaria. Malaria Journal, 20 (1) 470. doi: 10.1186/s12936-021-04003-7

Haematological response in experimental human Plasmodium falciparum and Plasmodium vivax malaria

2021

Journal Article

Development and evaluation of a new Plasmodium falciparum 3D7 blood stage malaria cell bank for use in malaria volunteer infection studies

Woolley, Stephen D., Fernandez, Melissa, Rebelo, Maria, Llewellyn, Stacey A., Marquart, Louise, Amante, Fiona H., Jennings, Helen E., Webster, Rebecca, Trenholme, Katharine, Chalon, Stephan, Moehrle, Joerg J., McCarthy, James S. and Barber, Bridget E. (2021). Development and evaluation of a new Plasmodium falciparum 3D7 blood stage malaria cell bank for use in malaria volunteer infection studies. Malaria Journal, 20 (1) 93, 93. doi: 10.1186/s12936-021-03627-z

Development and evaluation of a new Plasmodium falciparum 3D7 blood stage malaria cell bank for use in malaria volunteer infection studies